英文别名: |
Pioglitazone Hydrochloride;Pioglitazone HCl;Pioglitazone N-Oxide;[5-[[4-[2-(5-Ethyl-2-pyridinyl)ethoxy]phenyl]methyl]-2,4-] thiazolidinedione hydrochloride;5-(4-(2-(5-Ethylpyridin-2-yl)ethoxy)benzyl)thiazolidine-2,4-dione hydrochloride;Pioglitazone Hydroch;5-[[4-[2-(5-Ethyl-2-pyridinyl)ethoxy]phenyl]methyl]-2,4-thiazolidinedione monohydrochloride;5-[4-[2-(5-Ethyl-2-pyridyl)ethoxy]benzyl]-2,4-thiazolidinedione Hydrochloride;ACTOS;AD 4833;AD-4833;Effects of pioglitazone;Pioditazone hydrochloride;PIODLITAZONE HYDROCHLORIC;pioglitazone hydrochioride;U 72107A;5-[4-[2-(5-Ethyl-2-pyridinyl)ethoxy]benzyl]thiazolidine-2,4-dione hydrochloride;U-72107E;U-72107A;Pioglitazone (hydrochloride);Actos (TN);DSSTox_RID_80116;DSSTox_CID_24203;(+-)-5-(p-(2-(5-Ethyl-2-pyridyl)ethoxy)benzyl)-2,4-thiazolidinedione monohydrochloride;DSSTox_GSID_44203;C19H21ClN2O3S;Glustin;DSSTox_GS;Pioglitazone hydrochloride;Q-201584;DUETACT COMPONENT PIOGLITAZONE HYDROCHLORIDE;Pioglitazone hydrochloride (JP17/USP);Pioglitazone (as hydrochloride);NSC-758876;PIOGLITAZONE HYDROCHLORIDE COMPONENT OF DUETACT;Pioglitazone hydrochloride [USAN:USP];CHEMBL1715;5-(4-(2-(5-ethylpyridin-2-yl)ethoxy)benzyl)thiazolidine-2,4-dione HCl;STR-001;Pioglitazone Hydrochloride ,(S);5-[[4-[2-(5-Ethyl-2-pyridinyl)-etho xy]phenyl]methyl]-2,4-thiazolidinedione hydrochloride;HMS1922L05;Piomed;2,4-THIAZOLIDINEDIONE, 5-((4-(2-(5-ETHYL-2-PYRIDINYL)ETHOXY)PHENYL)METHYL)-, MONOHYDROCHLORIDE, (+/-)-;CHEBI:8229;Pioglitazone hydrochloride, European Pharmacopoeia (EP) Reference Standard;ACTOPLUS MET COMPONENT PIOGLITAZONE HYDROCHLORIDE;AC-1037;2,4-Thiazolidinedione, 5-((4-(2-(5-ethyl-2-pyridinyl)ethoxy)phenyl)methyl)-, monohydrochloride, (+-)-;5-({4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl}methyl)-1,3-thiazolidine-2,4-dione hydrochloride;BP164272;pioglitazone hydrochloride;Pioglitazone hydrochloride, United States Pharmacopeia (USP) Reference Standard;SPECTRUM1504401;(+/-)-5-(P-(2-(5-ETHYL-2-PYRIDYL)ETHOXY)BENZYL)-2,4-THIAZOLIDINEDIONE MONOHYDROCHLORIDE;Clorhidrato de pioglitazona;5-{4-[2-(5-ethylpyridin-2-yl)ethoxy]benzyl}-1,3-thiazolidine-2,4-dione hydrochloride;POZE;PIOGLITAZONE HYDROCHLORIDE (USP MONOGRAPH);5-[4-[2-(5-ethyl-2-pyridyl)ethoxy]benzyl]thiazolidine-2,4-dione hydrochloride;HY-14601;MLS001401386;127676-30-6;DTXSID3044203;BCP22942;KS-1186;P1901;5-[[4-[2-(5-ethyl-2-pyridyl)ethoxy]phenyl]methyl]thiazolidine-2,4-dione hydrochloride;AKOS015844016;FT-0601607;PIOGLITAZONE HYDROCHLORIDE [MI];UNII-JQT35NPK6C;Q27281642;PIOGLITAZONE HYDROCHLORIDE [USP MONOGRAPH];JQT35NPK6C;PIOGLITAZONE HYDROCHLORIDE [EP MONOGRAPH];AM20061770;PIOGLITAZONE HYDROCHLORIDE [VANDF];PIOGLITAZONE HYDROCHLORIDE [MART.];PIOGLITAZONE HYDROCHLORIDE [USP-RS];D00945;PIOGLITAZONE HYDROCHLORIDE COMPONENT OF OSENI;PIOGLITAZONE HYDROCHLORIDE COMPONENT OF ACTOPLUS MET;PIOGLITAZONE HYDROCHLORIDE [JAN];Pioglitazone for system suitability, Eur... |